Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04462562
What this trial is testing

Quantitative US for Evaluation of Hepatic Steatosis in NAFLD

Who this might be right for
Fatty LiverFatty Liver, Nonalcoholic
Seoul National University Hospital 173
Testing effectiveness (Phase 2)Study completedNCT00740610
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis
Gilead Sciences 124
Early research (Phase 1)WithdrawnNCT06138327
What this trial is testing

BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria

Who this might be right for
HyperoxaluriaNonalcoholic Fatty Liver DiseaseKidney Stone
BioMarin Pharmaceutical
Early research (Phase 1)Study completedNCT04897594
What this trial is testing

AVIATION Study: A Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TERN-201 in Patients With Non-Cirrhotic Non-Alcoholic Steatohepatitis

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 52
Testing effectiveness (Phase 2)Study completedNCT02633956
What this trial is testing

Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)

Who this might be right for
Nonalcoholic Steatohepatitis
Intercept Pharmaceuticals 84
Not applicableActive Not RecruitingNCT05507151
What this trial is testing

Effectiveness of Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Fatty Liver Disease
West Virginia University 30
Large-scale testing (Phase 3)Study completedNCT01418027
What this trial is testing

Combined Intensive and Conventional Exercise on Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
Shanghai Jiao Tong University School of Medicine 220
Not applicableActive Not RecruitingNCT07366710
What this trial is testing

Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PET

Who this might be right for
Glucose MetabolismNAFLD (Nonalcoholic Fatty Liver Disease)
Rigshospitalet, Denmark 36
Not applicableLooking for participantsNCT06035874
What this trial is testing

Effect of Bempedoic Acid on Liver Fat in Individuals With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes

Who this might be right for
Type 2 DiabetesNon Alcholic Fatty Liver Disease
Medanta, The Medicity, India 100
Not applicableStudy completedNCT05792423
What this trial is testing

Conditionally Increased Output (CIO) Enhanced Ultrasound System

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic SteatohepatitisFatty Liver
Massachusetts General Hospital 24
Early research (Phase 1)Study completedNCT04152473
What this trial is testing

Safety and Tolerability of Oral Proglumide for NASH

Who this might be right for
Nonalcoholic Steatohepatitis
Georgetown University 18
Not applicableLooking for participantsNCT06523179
What this trial is testing

Evaluation of Risk of hEpatocellular Carcinoma

Who this might be right for
NASHHCCGenetic Predisposition
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 500
Early research (Phase 1)Study completedNCT03950882
What this trial is testing

Assess the Pharmacokinetics of PXL770 After 4 Weeks of Treatment in Subjects With NAFLD

Who this might be right for
Nonalcoholic Fatty Liver
Poxel SA 17
Not applicableUnknownNCT03525769
What this trial is testing

Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusNonalcoholic Fatty Liver Disease (NAFLD)
Nanfang Hospital, Southern Medical University 10,000
Not applicableUnknownNCT04553796
What this trial is testing

Assessment of Nonalcoholic Fatty Liver Disease in Diabetic and Prediabetic Patients Using Noninvasive Methods.

Who this might be right for
Non Alcoholic Fatty Liver
Assiut University 150
Not applicableNot Yet RecruitingNCT06739486
What this trial is testing

Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non Alcholic Fatty Liver DiseaseHepatic SteatosisHepatic Fibrosis+1 more
Assiut University 100
Testing effectiveness (Phase 2)Ended earlyNCT05211284
What this trial is testing

Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US

Who this might be right for
Nonalcoholic Fatty Liver Disease
Zydus Therapeutics Inc. 4
Large-scale testing (Phase 3)Study completedNCT00820651
What this trial is testing

Efficacy and Safety of Diamel in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic SteatohepatitisInsulin Resistance
Catalysis SL 158
Not applicableStudy completedNCT00771108
What this trial is testing

Exercise Dose and Nonalcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
Washington University School of Medicine 33
Testing effectiveness (Phase 2)UnknownNCT04710524
What this trial is testing

FM101 Efficacy Study in Adults With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic Steatohepatitis
Future Medicine 60
Next Page